Dataset from Open-label Phase-4 Study to Examine the Change of Vision-related Quality of Life in Subjects With Diabetic Macular Edema (DME) During Treatment With Intravitreal Injections of 2 mg Aflibercept According to EU Label for the First Year of Treatment
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009423
下载链接
链接失效反馈官方服务：
资源简介：
To evaluate the change in quality of life (NEI VFQ 25) in subjects with DME during the first
year of treatment with aflibercept according to the EU Label.
创建时间：
2024-11-26
